Stacking & comparisons AOD-9604 is the fat-metabolism specialist of the GH family: it copies only the C-terminal lipolytic domain of growth hormone, so it stimulates fat breakdown without binding the GH receptor or raising IGF-1
Weight loss injections, including GLP-1 receptor agonists like semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro), have revolutionized obesity management
Another concern involves compounded GLP-1 medications
Once reward circuitry becomes dysregulated, dietary virtue alone cannot reset it
It is worth being clear about what this does and does not show
A dedicated deep-dive on combining copper peptides and retinol is coming to this blog soon, with more on sequencing, buffering and timing